Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Alex Philchenkov"'
Autor:
Oleksandra Lykhova, Michael Zavelevich, Alex Philchenkov, Nazar Vidasov, Tamara Kozak, Yulia Lozovska, Iryna Andrusyshyna, Anupam Bishayee, Tetiana Borikun, Natalia Lukianova, Vasyl Chekhun
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e895a21acee45726ddcbf63d772b532
https://doi.org/10.1007/s00210-023-02516-3
https://doi.org/10.1007/s00210-023-02516-3
Autor:
Alex Philchenkov, Tetiana S Ivanivska, D F Gluzman, Zvenislava V Masliak, Vasyl L Novak, L M Sklyarenko, S V Koval, Nataliia K. Rodionova, Yaroslava I Vyhovska, Mykhailo P Zavelevich
Publikováno v:
Annals of Hematology. 99:1543-1550
The major sources of the data on the hematological malignancies in the post-Chernobyl period in the regions of Ukraine differing by the levels of the residual contamination with radionuclides have been analyzed. According to the data collected from t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a051983e5eeddbbc2a8c0bd2dd8ba751
https://doi.org/10.1007/s00277-020-04076-5
https://doi.org/10.1007/s00277-020-04076-5
Autor:
Alex Philchenkov, L.N. Guslitser, D F Gluzman, M P Zavelevich, V N Zinchenko, T O Bezhenar, S V Koval
Publikováno v:
Experimental Oncology.
For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that are residually contaminated with long-lived radionuclides such as 137Cs, 90Sr. The previous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a66363ffdcd158b43ef04ad1aab22b99
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16434
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-2.16434
Publikováno v:
Experimental Oncology.
The 2017 revision of WHO Classification of tumors of hematopoietic and lymphoid tissues contains separate chapters on the immunodeficiency-associated lymphoproliferative disorders. In this mini-review, the brief description of pathological, immunophe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a5077b9247f456c2130c2eaafbc0701
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15795
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15795
Publikováno v:
Experimental Oncology. 38:224-237
During the past three decades, the deleterious consequences of Chornobyl accident including carcinogenic effects in the people who were accidentally exposed to radiation have been intensively studied. In particular, recent studies provided increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8793f6f7d214f2914504cf826aceb81
https://doi.org/10.31768/2312-8852.2016.38(4):224-237
https://doi.org/10.31768/2312-8852.2016.38(4):224-237
Autor:
D F Gluzman, Tetiana S Ivanivska, S V Koval, Alex Philchenkov, M P Zavelevich, L M Sklyarenko, A S Polishchuk
Publikováno v:
Experimental Oncology. 41
According to the modern concept, leukemic stem cells (LSC) in acute myeloid leukemia (AML) are distinct from the bulk of leukemic cells in bone marrow and peripheral blood of AML patients. Nevertheless, LSC are responsible for managing all the hierar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31894586ac987694e7683663e38c647
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-3.13492
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-3.13492
Autor:
Alex Philchenkov, Koh Miura, Volodymyr Tryndyak, Romano Silvestri, M P Zavelevich, Igor P. Pogribny, Dmitry Yu. Blokhin, Ludmila M. Kuiava
Publikováno v:
Cancer Biology & Therapy. 16:1820-1829
Recently, a series of novel arylthioindole compounds, potent inhibitors of tubulin polymerization and cancer cell growth, were synthesized. In the present study the effects of 2-(1H-pyrrol-3-yl)-3-((3,4,5-trimethoxyphenyl)thio)-1H-indole (ATI5 compou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f2a0b65cfc051fcbf7b8e06baa78a78
https://doi.org/10.1080/15384047.2015.1078026
https://doi.org/10.1080/15384047.2015.1078026
Publikováno v:
Critical Reviews in Oncogenesis 23(2018)1-2, 69-92
Radiation therapy remains one of the most effective cancer treatments. Nevertheless, biology-driven personalized radiation therapy that enables treatment according to the biological characteristics of the individual tumors and normal tissues still ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe90030ffe68aadcd0d5693cdde710f
https://pubmed.ncbi.nlm.nih.gov/29953368
https://pubmed.ncbi.nlm.nih.gov/29953368
Autor:
Alex Philchenkov
Publikováno v:
Critical reviews in oncogenesis. 23(1-2)
Currently, more than half of newly diagnosed cancer patients receive radiation treatment. However, the radioresistance of tumor cells as well as the early and late side effects limit the beneficial outcome of radiotherapy. Accordingly, the innovative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8d8a4f6f129b83bdc228084eac5f547
https://pubmed.ncbi.nlm.nih.gov/29953366
https://pubmed.ncbi.nlm.nih.gov/29953366